LOPINAVIR for Hiv infection: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 706 adverse event reports in the FDA FAERS database where LOPINAVIR was used for Hiv infection.
Most Reported Side Effects for LOPINAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 244 | 19.7% | 73 | 44 |
| Exposure during pregnancy | 184 | 14.8% | 22 | 26 |
| Virologic failure | 170 | 13.7% | 7 | 3 |
| Drug resistance | 134 | 10.8% | 9 | 3 |
| Off label use | 133 | 10.7% | 41 | 70 |
| Lipodystrophy acquired | 126 | 10.1% | 1 | 1 |
| Premature baby | 107 | 8.6% | 28 | 13 |
| Diplopia | 89 | 7.2% | 0 | 4 |
| Treatment failure | 89 | 7.2% | 1 | 1 |
| Premature delivery | 88 | 7.1% | 1 | 5 |
| Eyelid ptosis | 87 | 7.0% | 0 | 0 |
| Mitochondrial toxicity | 82 | 6.6% | 0 | 0 |
| Viral mutation identified | 76 | 6.1% | 0 | 0 |
| Progressive external ophthalmoplegia | 73 | 5.9% | 0 | 0 |
| Pathogen resistance | 54 | 4.4% | 0 | 3 |
Other Indications for LOPINAVIR
Covid-19 (108)
Prophylaxis against hiv infection (96)
Product used for unknown indication (68)
Antiretroviral therapy (47)
Antiviral treatment (34)
Foetal exposure during pregnancy (16)
Hepatitis viral (10)
Perinatal hiv infection (10)
Covid-19 pneumonia (9)
Hiv infection who clinical stage iii (9)
Other Drugs Used for Hiv infection
EMTRICITABINE\TENOFOVIR DISOPROXIL (27,672)
TENOFOVIR DISOPROXIL (19,662)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (15,794)
LAMIVUDINE (8,963)
DOLUTEGRAVIR (7,207)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (6,874)
RITONAVIR (6,739)
EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (5,840)
EFAVIRENZ (5,261)
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE (4,854)